CD44 and colorectal cancer: IGLC3&lt;sup&gt;-&lt;/sup&gt; tumor cells drive chemoresistance in colorectal cancer by polarizing SPP1&lt;sup&gt;+&lt;/sup&gt; macrophages via the CD44-Wnt-BTF3 axis.